Skip to main content
. 2021 Jan 28;8:577125. doi: 10.3389/fcell.2020.577125

Figure 7.

Figure 7

Expression of immune inhibiting factors between two immune prognostic model (IPM) recurrence risk groups. The TMB (A), and the expression levels of PD-1 (B), CTLA-4 (C), LAG3 (D), IDO (E), EZH2 (F), and B7H3 (G) were not significantly different between the two IPM recurrence risk groups (P > 0.05), but PD-L1 (H) was differently significant (P = 0.02).